Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: A case report

J Dermatol. 2019 May;46(5):e149-e151. doi: 10.1111/1346-8138.14716. Epub 2018 Dec 3.

Authors

Tatsuya Nihei¹, Yukiko Kiniwa¹, Yasutomo Mikoshiba¹, Satoru Joshita², Ryuhei Okuyama¹

Affiliations

¹ Department of Dermatology, Shinshu University School of Medicine, Nagano, Japan.
² Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Nagano, Japan.

PMID: 30506825
DOI: 10.1111/1346-8138.14716

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antiviral Agents / administration & dosage*
Hepacivirus / isolation & purification
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / immunology
Hepatitis C, Chronic / virology
Humans
Liver / drug effects
Liver / metabolism
Liver / virology
Male
Nails / pathology
Porphyria Cutanea Tarda / diagnosis*
Porphyria Cutanea Tarda / etiology
Porphyria Cutanea Tarda / pathology
Porphyria Cutanea Tarda / urine
Skin / pathology
Treatment Outcome
Uroporphyrins / metabolism
Uroporphyrins / urine

Substances

Antiviral Agents
Uroporphyrins